AGP Executive Report
Last update: 6 hours agoLyme Disease Vaccine Push in Europe: The EMA has agreed to study a potential Lyme disease vaccine from Valneva and Pfizer, after trials showed about 70% efficacy in people aged five and up; with tick season stretching longer across Europe and Slovenia among the higher-incidence countries, this could add a new layer of protection where there’s currently no approved vaccine. Wellness Trend Under Scrutiny: A “miserable detox retreat” is still thriving alongside weight-loss jabs, spotlighting how some wellness travelers keep paying for very low-calorie, tightly restricted programs despite growing debate about fasting-style approaches. MAID Debate in Canada: A Canadian activist says euthanasia is increasingly being framed as a fix for health-care and mental-health service gaps, arguing that palliative care and support beds are being outpaced. Health-Adjacent Media: A new Australian medical drama, The F Ward, is rolling out to major European markets including Slovenia, bringing hospital intern stories to streaming and TV audiences. Local Relevance: Slovenia is explicitly mentioned in the Lyme disease risk context, making the vaccine update the most directly health-focused item for our readers.
Note: AI summary from news headlines; neutral sources weighted more to help reduce bias in the result. Feedback is welcome. Please let us know if you have any comments or suggestions about the AGP Executive Report.
Perspectify News
